19-36546997-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020951.5(ZNF529):āc.1561T>Cā(p.Phe521Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000186 in 1,613,494 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_020951.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF529 | ENST00000591340.6 | c.1561T>C | p.Phe521Leu | missense_variant | 5/5 | 1 | NM_020951.5 | ENSP00000465578.1 | ||
ZNF529 | ENST00000334116.7 | c.1246T>C | p.Phe416Leu | missense_variant | 6/6 | 2 | ENSP00000334695.7 | |||
ZNF529 | ENST00000452073.2 | c.205+561T>C | intron_variant | 3 | ENSP00000465917.1 | |||||
ZNF529 | ENST00000590656.1 | c.139+393T>C | intron_variant | 3 | ENSP00000468594.1 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151742Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461752Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727164
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151742Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74098
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 20, 2023 | The c.1561T>C (p.F521L) alteration is located in exon 6 (coding exon 4) of the ZNF529 gene. This alteration results from a T to C substitution at nucleotide position 1561, causing the phenylalanine (F) at amino acid position 521 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at